These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27941771)

  • 1. Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation.
    Fuji S; Löffler J; Savani BN; Einsele H; Kapp M
    Bone Marrow Transplant; 2017 May; 52(5):657-662. PubMed ID: 27941771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.
    Fuji S; Rovó A; Ohashi K; Griffith M; Einsele H; Kapp M; Mohty M; Majhail NS; Engelhardt BG; Tichelli A; Savani BN
    Bone Marrow Transplant; 2016 Aug; 51(8):1041-9. PubMed ID: 27042848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
    Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
    Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.
    Sopfe J; Campbell K; Keating AK; Pyle L; Liu AK; Verneris MR; Giller RH; Forlenza GP
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28626. PubMed ID: 33480469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Fungal Infections in Solid Organ and Hematopoietic Stem Cell Transplantation.
    De La Cruz O; Silveira FP
    Clin Chest Med; 2017 Dec; 38(4):727-739. PubMed ID: 29128021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation.
    Fuji S; Kim SW; Mori S; Fukuda T; Kamiya S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Honda O; Kuwahara S; Tanosaki R; Heike Y; Tobinai K; Takaue Y
    Transplantation; 2007 Oct; 84(7):814-20. PubMed ID: 17984832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.
    Sahin U; Toprak SK; Atilla PA; Atilla E; Demirer T
    J Infect Chemother; 2016 Aug; 22(8):505-14. PubMed ID: 27344206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
    Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR
    Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition (PN) exposure in hematopoietic stem cell transplant (HSCT) recipients.
    Sheean P; Braunschweig C
    JPEN J Parenter Enteral Nutr; 2006; 30(4):345-50. PubMed ID: 16804133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early hyperglycemia after allogenic kidney transplantation.
    Wyzgal J; Paczek L; Ziolkowski J; Pawlowska M; Rowiński W; Durlik M
    Ann Transplant; 2007; 12(1):40-5. PubMed ID: 17953142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.
    Tamura K; Drew R
    Drugs Today (Barc); 2008 Jul; 44(7):515-30. PubMed ID: 18806902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: a single center study of 190 recipients.
    Li L; Wang J; Zhang W; Yang J; Chen L; Lv S
    Scand J Infect Dis; 2012 Feb; 44(2):100-7. PubMed ID: 22066677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
    Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
    J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusarium infection in hematopoietic stem cell transplant recipients.
    Nucci M; Marr KA; Queiroz-Telles F; Martins CA; Trabasso P; Costa S; Voltarelli JC; Colombo AL; Imhof A; Pasquini R; Maiolino A; Souza CA; Anaissie E
    Clin Infect Dis; 2004 May; 38(9):1237-42. PubMed ID: 15127334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trends in fungal infections as a cause of death in hematopoietic stem cell transplant recipients: an autopsy study.
    Alsharif M; Cameron SE; Young JA; Savik K; Henriksen JC; Gulbahce HE; Pambuccian SE
    Am J Clin Pathol; 2009 Nov; 132(5):746-55. PubMed ID: 19846817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation--focus on aspergillosis.
    Nucci M; Anaissie E
    Clin Chest Med; 2009 Jun; 30(2):295-306, vii. PubMed ID: 19375636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal colonization of the respiratory tract in allogeneic and autologous hematopoietic stem cell transplant recipients: a study of 573 transplanted patients.
    Markowski J; Helbig G; Widziszowska A; Likus W; Kyrcz-Krzemień S; Jarosz U; Dziubdziela W; Markiewicz M
    Med Sci Monit; 2015 Apr; 21():1173-80. PubMed ID: 25907308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus after allogeneic hematopoietic stem cell transplantation.
    Wędrychowicz A; Ciechanowska M; Stelmach M; Starzyk J
    Horm Res Paediatr; 2013; 79(1):44-50. PubMed ID: 23296512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.